Lensar (LNSR) Other Non-Current Liabilities (2019 - 2026)
Lensar (LNSR) reported Other Non-Current Liabilities of $16.2 million for Q1 2026, down 68.5% year-over-year from $51.6 million in Q1 2025, and down 59.58% on a QoQ basis from $40.2 million in Q4 2025.
Lensar (LNSR) has 8 years of Other Non-Current Liabilities data on file, last reported at $16.2 million in Q1 2026.
- Quarterly Other Non-Current Liabilities fell 68.5% year-over-year to $16.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.2 million (down 68.5% YoY) and the FY2025 annual result came in at $40.2 million, up 34.63% from the prior year.
- Other Non-Current Liabilities eased to $16.2 million in Q1 2026 per LNSR's latest filing, from $40.2 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $51.6 million in Q1 2025 and bottomed at $52000.0 in Q1 2022.
- The 5-year median for Other Non-Current Liabilities is $9.8 million (2023), against an average of $16.1 million.
- Peak annual rise in Other Non-Current Liabilities reached 5137.89% in 2024, while the deepest fall reached 97.18% in 2024.
- Tracing LNSR's Other Non-Current Liabilities over 5 years: stood at $167000.0 in 2022, then jumped by 241.32% to $570000.0 in 2023, then soared by 5137.89% to $29.9 million in 2024, then surged by 34.63% to $40.2 million in 2025, then plunged by 59.58% to $16.2 million in 2026.
- Per Business Quant, the three latest LNSR Other Non-Current Liabilities figures stand at $16.2 million (Q1 2026), $40.2 million (Q4 2025), and $911000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.25 Mn |
| Dec 31, 2025 | 40.19 Mn |
| Sep 30, 2025 | 911,000.00 |
| Jun 30, 2025 | 47.24 Mn |
| Mar 31, 2025 | 51.57 Mn |
| Dec 31, 2024 | 29.86 Mn |
| Sep 30, 2024 | 205,000.00 |
| Jun 30, 2024 | 11.89 Mn |
| Mar 31, 2024 | 7.96 Mn |
| Dec 31, 2023 | 570,000.00 |
| Sep 30, 2023 | 7.26 Mn |
| Jun 30, 2023 | 11.60 Mn |
| Dec 31, 2022 | 167,000.00 |
| Mar 31, 2022 | 52,000.00 |
| Dec 31, 2021 | 69,000.00 |
| Sep 30, 2021 | 90,000.00 |
| Jun 30, 2021 | 72,000.00 |
| Mar 31, 2021 | 97,000.00 |
| Dec 31, 2020 | 129,000.00 |
| Sep 30, 2020 | 51,000.00 |
| Dec 31, 2019 | 310,000.00 |